APO Research
Talk to an analyst

APO RESEARCH · REPORT

Desmopressin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Desmopressin Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchDesmopressin Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Desmopressin Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Desmopressin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Desmopressin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Desmopressin Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Desmopressin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Desmopressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Desmopressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Desmopressin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Desmopressin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Desmopressin market include Shanghai Soho-Yiming Pharmaceuticals, Ferring Pharmaceuticals and Cadila Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Desmopressin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Desmopressin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Desmopressin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Desmopressin market size, projected growth trends, production technologies, key applications, and end-use industries.

Desmopressin Segment by Company

Shanghai Soho-Yiming Pharmaceuticals

Ferring Pharmaceuticals

Cadila Healthcare

Desmopressin Segment by Type

Oral

Intravenous Injection

Nasal Spray

Desmopressin Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Desmopressin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Desmopressin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Desmopressin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Desmopressin significant trends, drivers, influence factors in global and regions.

6. To analyze Desmopressin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desmopressin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Desmopressin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desmopressin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Desmopressin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Desmopressin industry.

Chapter 3: Detailed analysis of Desmopressin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Desmopressin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Desmopressin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Desmopressin Industry Trends Table 2. Desmopressin Industry Drivers Table 3. Desmopressin Industry Opportunities and Challenges Table 4. Desmopressin Industry Restraints Table 5. Global Desmopressin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Desmopressin Revenue Share by Company (2021-2026) Table 7. Global Desmopressin Sales Volume by Company (kg) & (2021-2026) Table 8. Global Desmopressin Sales Volume Share by Company (2021-2026) Table 9. Global Desmopressin Average Price (US$/g) of Company (2021-2026) Table 10. Global Desmopressin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Desmopressin Key Company Manufacturing Base & Headquarters Table 12. Global Desmopressin Company, Product Type & Application Table 13. Global Desmopressin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Desmopressin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Intravenous Injection Table 19. Significant Companies of Nasal Spray Table 20. Global Desmopressin Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Desmopressin Sales Volume by Type (2021-2026) & (kg) Table 22. Global Desmopressin Sales Volume by Type (2027-2032) & (kg) Table 23. Global Desmopressin Sales Volume Share by Type (2021-2026) Table 24. Global Desmopressin Sales Volume Share by Type (2027-2032) Table 25. Global Desmopressin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Desmopressin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Desmopressin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Desmopressin Sales Value Share by Type (2021-2026) Table 29. Global Desmopressin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Hospital Pharmacies Table 33. Global Desmopressin Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Desmopressin Sales Volume by Application (2021-2026) & (kg) Table 35. Global Desmopressin Sales Volume by Application (2027-2032) & (kg) Table 36. Global Desmopressin Sales Volume Share by Application (2021-2026) Table 37. Global Desmopressin Sales Volume Share by Application (2027-2032) Table 38. Global Desmopressin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Desmopressin Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Desmopressin Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Desmopressin Sales Value Share by Application (2021-2026) Table 42. Global Desmopressin Sales Value Share by Application (2027-2032) Table 43. Global Desmopressin Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Desmopressin Sales by Region (2021-2026) & (kg) Table 45. Global Desmopressin Sales Market Share by Region (2021-2026) Table 46. Global Desmopressin Sales by Region (2027-2032) & (kg) Table 47. Global Desmopressin Sales Market Share by Region (2027-2032) Table 48. Global Desmopressin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Desmopressin Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Desmopressin Sales Value Share by Region (2021-2026) Table 51. Global Desmopressin Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Desmopressin Sales Value Share by Region (2027-2032) Table 53. Global Desmopressin Market Average Price (US$/g) by Region (2021-2026) Table 54. Global Desmopressin Market Average Price (US$/g) by Region (2027-2032) Table 55. Global Desmopressin Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Desmopressin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Desmopressin Sales by Country (2021-2026) & (kg) Table 58. Global Desmopressin Sales Market Share by Country (2021-2026) Table 59. Global Desmopressin Sales by Country (2027-2032) & (kg) Table 60. Global Desmopressin Sales Market Share by Country (2027-2032) Table 61. Global Desmopressin Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Desmopressin Sales Value Market Share by Country (2021-2026) Table 63. Global Desmopressin Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Desmopressin Sales Value Market Share by Country (2027-2032) Table 65. Shanghai Soho-Yiming Pharmaceuticals Company Information Table 66. Shanghai Soho-Yiming Pharmaceuticals Business Overview Table 67. Shanghai Soho-Yiming Pharmaceuticals Desmopressin Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. Shanghai Soho-Yiming Pharmaceuticals Desmopressin Product Portfolio Table 69. Shanghai Soho-Yiming Pharmaceuticals Recent Development Table 70. Ferring Pharmaceuticals Company Information Table 71. Ferring Pharmaceuticals Business Overview Table 72. Ferring Pharmaceuticals Desmopressin Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Ferring Pharmaceuticals Desmopressin Product Portfolio Table 74. Ferring Pharmaceuticals Recent Development Table 75. Cadila Healthcare Company Information Table 76. Cadila Healthcare Business Overview Table 77. Cadila Healthcare Desmopressin Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. Cadila Healthcare Desmopressin Product Portfolio Table 79. Cadila Healthcare Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Desmopressin Distributors List Table 83. Desmopressin Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Desmopressin Product Image Figure 2. Global Desmopressin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Desmopressin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Desmopressin Sales (2021-2032) & (kg) Figure 5. Global Desmopressin Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Desmopressin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Intravenous Injection Image Figure 11. Nasal Spray Image Figure 12. Global Desmopressin Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Desmopressin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Desmopressin Sales Volume Share by Type (2021-2032) Figure 15. Global Desmopressin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Desmopressin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Desmopressin Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Global Desmopressin Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Desmopressin Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Desmopressin Sales Volume Share by Application (2021-2032) Figure 24. Global Desmopressin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Desmopressin Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Desmopressin Sales Value Share by Application (2021-2032) Figure 27. Global Desmopressin Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Desmopressin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Desmopressin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Desmopressin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Desmopressin Sales Value (2021-2032) & (US$ Million) Figure 32. North America Desmopressin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Desmopressin Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Desmopressin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Desmopressin Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Desmopressin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Desmopressin Sales Value (2021-2032) & (US$ Million) Figure 38. South America Desmopressin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Desmopressin Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Desmopressin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Desmopressin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Desmopressin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Desmopressin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Desmopressin Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Desmopressin Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Intravenous Injection
  • Nasal Spray
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Shanghai Soho-Yiming Pharmaceuticals
  • Ferring Pharmaceuticals
  • Cadila Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Desmopressin Sales Value (2021-2032)
  4. 1.2.2 Global Desmopressin Sales Volume (2021-2032)
  5. 1.2.3 Global Desmopressin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Desmopressin Market Dynamics
  1. 2.1 Desmopressin Industry Trends
  2. 2.2 Desmopressin Industry Drivers
  3. 2.3 Desmopressin Industry Opportunities and Challenges
  4. 2.4 Desmopressin Industry Restraints
3 Desmopressin Market by Company
  1. 3.1 Global Desmopressin Company Revenue Ranking in 2025
  2. 3.2 Global Desmopressin Revenue by Company (2021-2026)
  3. 3.3 Global Desmopressin Sales Volume by Company (2021-2026)
  4. 3.4 Global Desmopressin Average Price by Company (2021-2026)
  5. 3.5 Global Desmopressin Company Ranking (2024-2026)
  6. 3.6 Global Desmopressin Company Manufacturing Base and Headquarters
  7. 3.7 Global Desmopressin Company Product Type and Application
  8. 3.8 Global Desmopressin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Desmopressin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Desmopressin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Desmopressin Market by Type
  1. 4.1 Desmopressin Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Intravenous Injection
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Desmopressin Sales Volume by Type
  6. 4.2.1 Global Desmopressin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Desmopressin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Desmopressin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Desmopressin Sales Value by Type
  10. 4.3.1 Global Desmopressin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Desmopressin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Desmopressin Sales Value Share by Type (2021-2032)
5 Desmopressin Market by Application
  1. 5.1 Desmopressin Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Desmopressin Sales Volume by Application
  6. 5.2.1 Global Desmopressin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Desmopressin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Desmopressin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Desmopressin Sales Value by Application
  10. 5.3.1 Global Desmopressin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Desmopressin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Desmopressin Sales Value Share by Application (2021-2032)
6 Desmopressin Regional Sales and Value Analysis
  1. 6.1 Global Desmopressin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Desmopressin Sales by Region (2021-2032)
  3. 6.2.1 Global Desmopressin Sales by Region: 2021-2026
  4. 6.2.2 Global Desmopressin Sales by Region (2027-2032)
  5. 6.3 Global Desmopressin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Desmopressin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Desmopressin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Desmopressin Sales Value by Region (2027-2032)
  9. 6.5 Global Desmopressin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Desmopressin Sales Value (2021-2032)
  12. 6.6.2 North America Desmopressin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Desmopressin Sales Value (2021-2032)
  15. 6.7.2 Europe Desmopressin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Desmopressin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Desmopressin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Desmopressin Sales Value (2021-2032)
  21. 6.9.2 South America Desmopressin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Desmopressin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Desmopressin Sales Value Share by Country, 2025 VS 2032
7 Desmopressin Country-level Sales and Value Analysis
  1. 7.1 Global Desmopressin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Desmopressin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Desmopressin Sales by Country (2021-2032)
  4. 7.3.1 Global Desmopressin Sales by Country (2021-2026)
  5. 7.3.2 Global Desmopressin Sales by Country (2027-2032)
  6. 7.4 Global Desmopressin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Desmopressin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Desmopressin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Desmopressin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Desmopressin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Desmopressin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Desmopressin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Desmopressin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Desmopressin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Desmopressin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Desmopressin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Desmopressin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Desmopressin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Desmopressin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Desmopressin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Desmopressin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Desmopressin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Desmopressin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Desmopressin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Desmopressin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Desmopressin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Desmopressin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Desmopressin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Desmopressin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Desmopressin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Desmopressin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Desmopressin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Desmopressin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Desmopressin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Desmopressin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Desmopressin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Desmopressin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Desmopressin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Desmopressin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Desmopressin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Desmopressin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Desmopressin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Desmopressin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Desmopressin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Desmopressin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Desmopressin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Desmopressin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Desmopressin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Desmopressin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Desmopressin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Desmopressin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Desmopressin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Desmopressin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Desmopressin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Desmopressin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Desmopressin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Desmopressin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Desmopressin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Desmopressin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Desmopressin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Desmopressin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Desmopressin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Desmopressin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Desmopressin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Desmopressin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Desmopressin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Desmopressin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Desmopressin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Desmopressin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Desmopressin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Desmopressin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Desmopressin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Desmopressin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Desmopressin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Desmopressin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Desmopressin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Desmopressin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Desmopressin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Desmopressin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Desmopressin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Desmopressin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Desmopressin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Desmopressin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Desmopressin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Desmopressin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Desmopressin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Desmopressin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Desmopressin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Desmopressin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Desmopressin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Desmopressin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Desmopressin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Soho-Yiming Pharmaceuticals
  2. 8.1.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
  3. 8.1.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  4. 8.1.3 Shanghai Soho-Yiming Pharmaceuticals Desmopressin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Soho-Yiming Pharmaceuticals Desmopressin Product Portfolio
  6. 8.1.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
  7. 8.2 Ferring Pharmaceuticals
  8. 8.2.1 Ferring Pharmaceuticals Company Information
  9. 8.2.2 Ferring Pharmaceuticals Business Overview
  10. 8.2.3 Ferring Pharmaceuticals Desmopressin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ferring Pharmaceuticals Desmopressin Product Portfolio
  12. 8.2.5 Ferring Pharmaceuticals Recent Developments
  13. 8.3 Cadila Healthcare
  14. 8.3.1 Cadila Healthcare Company Information
  15. 8.3.2 Cadila Healthcare Business Overview
  16. 8.3.3 Cadila Healthcare Desmopressin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cadila Healthcare Desmopressin Product Portfolio
  18. 8.3.5 Cadila Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Desmopressin Value Chain Analysis
  2. 9.1.1 Desmopressin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Desmopressin Sales Mode & Process
  6. 9.2 Desmopressin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Desmopressin Distributors
  9. 9.2.3 Desmopressin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst